Not independent
Tenure on this board
15.3 yrs
Meeting calendar
CERS · Annual meeting · Tuesday, June 2, 2026
Cerus Corp
2 nominees · 4 ballot items.
Election of two directors; approval of amendment and restatement of the 2024 Equity Incentive Plan to increase share reserve by 10,000,000 shares; advisory vote to approve executive compensation (say-on-pay); ratification of Ernst & Young LLP as independent auditors.
Market cap
$637M
1Y TSR
+104.3%
Board grade
C+
Record date
Apr 10, 2026
Filing
DEF 14A
Meeting concluded · Jun 2, 2026
Follow how the vote landed and what changed on Cerus Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Directors
ManagementBoard: FORElect two director nominees (William M. Greenman and Ann Lucena) to hold office until the 2029 Annual Meeting.
- 2
Amendment and Restatement of the Company's 2024 Equity Incentive Plan
ManagementBoard: FORApprove an amendment and restatement of the 2024 Equity Incentive Plan to increase the aggregate number of shares authorized for issuance by 10,000,000 shares and related changes.
- 3
Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement.
- 4
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the selection by the Audit Committee of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026.
Director elections
Nominees on the ballot2
Independent
Tenure on this board
5.0 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | ARK Investment Management LLC | 9.6% | 19,161,148 | $35M |
| 2 | Soleus Capital Management, L.P. | 5.4% | 10,753,700 | $20M |
| 3 | BAKER BROS. ADVISORS LP | 5.0% | 10,008,345 | $18M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 8,131,778 | $15M |
| 5 | BlackRock, Inc. | 4.0% | 8,084,975 | $15M |
| 6 | BlackRock, Inc. | 3.9% | 7,809,293 | $14M |
| 7 | WASATCH ADVISORS LP | 2.6% | 5,281,136 | $10M |
| 8 | Amova Asset Management Americas, Inc. | 2.3% | 4,516,606 | $8M |
| 9 | Sumitomo Mitsui Trust Group, Inc. | 2.3% | 4,516,606 | $8M |
| 10 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 2.1% | 4,241,411 | $8M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Cerus Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$724M
Cross Country Healthcare IncCCRN
Special meeting·Jul 16, 2026·$428M
Seer IncSEER
Annual meeting·Jul 28, 2026·$119M
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Reference
Frequently asked questions
- When is the Cerus Corp 2026 annual meeting?
- Cerus Corp (CERS) holds its 2026 annual shareholder meeting on Tuesday, June 2, 2026.
- What is the record date for the Cerus Corp 2026 meeting?
- The record date for the Cerus Corp 2026 meeting is Friday, April 10, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Cerus Corp's 2026 meeting?
- The board is presenting 2 director nominees at the Cerus Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Cerus Corp 2026 meeting?
- Shareholders will vote on 4 proposals at the Cerus Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.